Despite the fact that it inhibits HIF-1α, microtubules, and tumor angiogenesis and has a role in antiproliferation and antiangiogenesis, the role and mechanism of 2-ME2 in CML are still unclear. Here, HIF1A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.